Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAAH Availability in Psychiatric Disorders PET Study
NCT04404712Phase 1Terminated
- Sponsor
- Yale University
- Start
- Sep 2020
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [11C]MK-3168 in post-traumatic stress disorder (PTSD), alcohol use disorder (AUD) and psychosis, sponsored by Yale University. Primary endpoint: Total distribution of [11C]MK-3168 in the brain. Started Sep 2020; status: terminated.
02
Drugs
[11C]MK-3168
03
Conditions
post-traumatic stress disorder (PTSD)alcohol use disorder (AUD)psychosis
Beyond the preview
Go deeper on NCT04404712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04404712.